Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PCSK9 Patent Case: Praluent Injunction Vacated, But May Well Return

Related Content

Praluent Fate Uncertain After Amgen Wins PCSK9 Patent Battle

Mar 17 2016

‘Between A Rock And A Hard Place,’ Court Issues Injunction To Halt Praluent Sales

Jan 06 2017

Praluent Injunction Goes Unmentioned At PCSK9 Patent Case Appeal

Jun 06 2017

Related Companies

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Additional Topics

United States Intellectual Property Legal Issues Commercial BioPharmaceutical Cardiovascular Metabolic Disorders

More from Legal & IP

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window